33713-02-9

Upstream product

• 54591-64-9 3-hydroxy-4-methyl-5-nitrobenzoic acid 
• 77-78-1 dimethyl sulfate 
• 72922-60-2 methyl 3-amino-4-methyl-5-nitrobenzoate 
• 74-88-4 methyl iodide 
• 16533-71-4 3,5-dinitro-p-toluic acid 
• 49592-71-4 methyl 4-methyl-3,5-dinitrobenzoate 
• 1057652-89-7 Methyl 3-fluoro-4-methyl-5-nitro-benzoate 
• 125229-13-2 3-hydroxy-4-methyl-5-nitrobenzoic acid methyl ester 

Downstream Products

• 1002110-78-2 3-Methoxy-4-methyl-5-nitrobenzoic acid 
• 33580-38-0 3-Methoxy-5-nitro-p-toluidin 
• 145183-06-8 3,5-dimethoxy-2-methyl-aniline 
• 16024-31-0 2,4-dimethoxy-6-nitro-toluene 
• 33580-39-1 3-Methoxy-5-nitro-p-kresol 
• 33580-41-5 2-Methyl-3,5-dimethoxy-jodbenzol 
• 136763-91-2 3-methoxy-5-nitro-4-(2-oxoethyl)benzoic acid methyl ester 
• 136763-84-3 (E)-(+/-)-4-(1-hydroxy-2-methoxy-2,4-pentadienyl)-3-methoxy-5-nitrobenzoic acid methyl ester 
• 136763-83-2 4-formyl-3-methoxy-5-nitrobenzoic acid methyl ester 
• 33580-37-9 3-Methoxy-5-nitro-p-toluylsaeureamid 

Relevant academic research and scientific papers

Orally active zwitterionic factor Xa inhibitors with long duration of action

We have optimized 2-aminomethylphenylamine derivative as a factor Xa inhibitor. Several polar functional groups were introduced in the central phenyl ring, and we focused on zwitter ionic compound showing continuous inhibitory activity in oral administrat

PROLYL HYDROXYLASE INHIBITORS

The invention described herein relates to certain 2,4-dioxo-l,2,3,4-tetrahydro-7- quinazolinecarboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.